Opportunity Information: Apply for RFA DA 09 009
Apply for RFA DA 09 009
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Brain Imaging Studies of Negative Reinforcement in Humans (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Nov 5, 2008 and posted on Nov 5, 2008.
- Applicants must submit their applications by Feb 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments Small businesses Native American tribal governments (Federally recognized) Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Brain Imaging Studies of Negative Reinforcement in Humans (R21)" (RFA-DA-09-009), was issued by the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH) to encourage exploratory and early stage human research on how the brain supports negative reinforcement, also described here as avoidance learning. The central aim is to build and energize a clinical neuroscience research program focused on how aversive events shape behavior, particularly because preclinical evidence has brought negative reinforcement back into focus as an important driver in the development and maintenance of substance abuse. In practical terms, NIDA is looking for studies that can help explain how people learn and sustain behaviors or mental strategies that reduce, prevent, or escape unpleasant outcomes, and how those processes relate to addiction risk, addiction persistence, or relapse.
The announcement emphasizes a gap in current knowledge: compared with the extensive understanding of brain systems involved in pursuing rewards and positive outcomes, the neural mechanisms involved in avoiding negative outcomes are less well mapped in humans. For the purposes of this FOA, negative reinforcement and avoidance learning are treated as equivalent concepts and are defined broadly. They include any learned behaviors or cognitive strategies that are maintained because they minimize or eliminate aversive events. Importantly, "aversive events" are not limited to external threats or unpleasant environmental stimuli; they can also be internal states, such as anxiety, stress, withdrawal symptoms, craving-related distress, or other uncomfortable bodily or emotional conditions. This framing aligns closely with modern addiction theories in which substance use can become a way to reduce negative internal states, making avoidance and escape learning clinically relevant.
Because this is an R21 Exploratory/Developmental grant mechanism, the FOA is geared toward early, innovative work rather than fully mature, large-scale programs. NIDA explicitly expects applications that are exploratory, hypothesis-generating, or proof-of-concept in nature. Proposed projects should aim to identify brain regions and brain processes in humans that support avoidance learning and negative reinforcement, especially as they relate to substance use and misuse. The opportunity also invites methodological innovation: applicants may propose the development of new human tasks or paradigms that can be used in future brain imaging studies to more precisely target neural systems involved in avoidance learning. In other words, proposals can focus not only on running imaging studies with established paradigms, but also on creating and validating better experimental tasks that will make subsequent imaging research more informative and clinically useful.
The FOA allows research to be conducted in multiple types of participant groups. Studies may involve healthy individuals, people who currently abuse substances, people in abstinence or recovery, or individuals considered at elevated risk for substance abuse. Regardless of the population selected, every application must clearly connect the proposed work to advancing understanding of substance abuse. That relevance requirement is central: the science can be basic and mechanistic, but it needs to be framed in a way that informs addiction research, such as clarifying why certain individuals are vulnerable, how avoidance-driven processes contribute to compulsive drug seeking, or how aversive internal states and escape learning may sustain use or contribute to relapse.
Administratively, this is a discretionary grant opportunity using the NIH R21 funding instrument. The CFDA number is 93.279 (Drug Abuse and Addiction Research Programs). The total estimated funding listed is $3,000,000, with an award ceiling of $200,000. There is no cost sharing or matching requirement. The FOA was posted on November 5, 2008, with an original and current closing date of February 19, 2009, and an archive date of March 22, 2009.
Eligibility is broad and includes many organization types: public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, independent school districts, state, county, city, township, and special district governments, public housing authorities, and Native American tribal governments and organizations. The FOA also notes additional eligible applicants such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, U.S. territories or possessions, regional organizations, foreign (non-U.S.) entities, and eligible federal agencies.
Overall, the opportunity is designed to push the field toward a clearer human neuroscience account of avoidance learning and negative reinforcement, with a strong emphasis on how these mechanisms intersect with substance abuse. It supports early-stage imaging-oriented research and task development that can lay the groundwork for larger future studies, with the long-term goal of improving the understanding of addiction-related behavior driven by escaping or preventing aversive experiences.
Frequently Asked Questions (FAQs)
What is the title and identifier of this funding opportunity?
The opportunity is titled "Brain Imaging Studies of Negative Reinforcement in Humans (R21)" and is identified as RFA-DA-09-009.
Which agency is offering this grant?
This funding opportunity was issued by the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH).
What is the purpose of this funding opportunity?
The purpose is to encourage exploratory and early stage human research using brain imaging to better understand negative reinforcement (also referred to here as avoidance learning), particularly how aversive events shape behavior and how those processes relate to substance abuse, addiction persistence, and relapse.
What does "negative reinforcement" mean in this announcement?
For this opportunity, negative reinforcement and avoidance learning are treated as equivalent. They are defined broadly as learned behaviors or cognitive/mental strategies that are maintained because they reduce, prevent, or allow escape from aversive events or unpleasant outcomes.
What counts as an "aversive event" under this FOA?
Aversive events can be external (unpleasant environmental stimuli or threats) or internal states. Internal aversive states can include anxiety, stress, withdrawal symptoms, craving-related distress, or other uncomfortable bodily or emotional conditions.
Why is NIDA emphasizing avoidance learning and negative reinforcement?
The announcement highlights a knowledge gap: compared to the well-developed understanding of human brain systems involved in reward pursuit and positive outcomes, the neural mechanisms supporting avoidance of negative outcomes are less well mapped in humans. Preclinical evidence has also renewed attention on negative reinforcement as an important driver in the development and maintenance of substance abuse.
What types of studies is NIDA looking for?
NIDA is looking for human brain imaging studies aimed at identifying brain regions and processes that support avoidance learning/negative reinforcement, especially in ways that inform substance abuse research. The FOA also welcomes exploratory, hypothesis-generating, and proof-of-concept approaches.
Is this intended for large, mature research programs?
No. This uses the NIH R21 Exploratory/Developmental mechanism and is geared toward early, innovative work rather than fully mature, large-scale programs.
Can applicants propose new experimental tasks or paradigms?
Yes. The opportunity explicitly invites methodological innovation, including the development of new human tasks or paradigms that can be used in future brain imaging studies to more precisely target neural systems involved in avoidance learning.
Do proposed projects have to involve brain imaging?
The opportunity is framed around "brain imaging studies" and emphasizes identifying brain regions and brain processes in humans that support avoidance learning. It also supports task/paradigm development intended for use in future imaging studies.
Which participant populations are allowed?
Studies may involve healthy individuals, people who currently abuse substances, people in abstinence or recovery, or individuals considered at elevated risk for substance abuse.
Is there a required link to substance abuse research?
Yes. Regardless of the population or approach, each application must clearly connect the proposed work to advancing understanding of substance abuse. The science may be basic and mechanistic, but it must be framed to inform addiction research (for example, vulnerability, persistence, relapse, or avoidance/escape processes that sustain use).
What kinds of addiction-related questions might this FOA help address?
Based on the description, funded work may help clarify how avoidance-driven processes contribute to compulsive drug seeking, why certain individuals may be more vulnerable to addiction, how aversive internal states (like stress or withdrawal) shape behavior, and how escape learning may sustain use or contribute to relapse.
What grant mechanism is being used?
This is an NIH R21 Exploratory/Developmental grant.
What is the CFDA number for this program?
The CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).
How much total funding is estimated for this opportunity?
The total estimated funding listed is $3,000,000.
What is the award ceiling listed in the announcement?
The award ceiling is $200,000.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
When was the FOA posted, and what are the key dates?
The FOA was posted on November 5, 2008. The original and current closing date is February 19, 2009. The archive date is March 22, 2009.
Who is eligible to apply?
Eligibility is broad and includes: public and private institutions of higher education; nonprofit organizations (with and without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; independent school districts; state, county, city, township, and special district governments; public housing authorities; and Native American tribal governments and organizations.
Are specific institution types (like HBCUs or Hispanic-serving institutions) eligible?
Yes. The FOA notes eligibility for historically Black colleges and universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among eligible applicants.
Are foreign (non-U.S.) organizations eligible?
Yes. The FOA includes foreign (non-U.S.) entities among eligible applicants.
Are U.S. territories or regional organizations eligible?
Yes. The FOA lists U.S. territories or possessions and regional organizations among eligible applicants.
Does the opportunity allow participation by federal agencies?
Yes. The FOA includes eligible federal agencies among allowable applicants.
What is the long-term goal of this funding opportunity?
The long-term goal is to push the field toward a clearer human neuroscience account of avoidance learning and negative reinforcement as they intersect with substance abuse, supporting early-stage imaging-oriented research and task development that can lay the groundwork for larger future studies.
Browse more opportunities from the same category: Education Health
Next opportunity: Fiscal Year 2009 Emergency Management Performance Grant (EMPG)
Previous opportunity: Brain Imaging Studies of Negative Reinforcement in Humans (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 09 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 09 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Instrument Development for Biomedical Applications (R21) Apply for RFA RR 09 001 Funding Number: RFA RR 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Erythropoiesis Stimulating Agents and Tumor Progression (R01) Apply for PA 09 023 Funding Number: PA 09 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Erythropoiesis Stimulating Agents and Tumor Progression (R21) Apply for PA 09 024 Funding Number: PA 09 024 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cancer Institute Program Project (P01) Applications Apply for PAR 09 025 Funding Number: PAR 09 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 09 026 Funding Number: PAR 09 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25) Apply for RFA MH 09 110 Funding Number: RFA MH 09 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Shared Instrumentation Grant Program (S10) Apply for PAR 09 028 Funding Number: PAR 09 028 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Mutant Mouse Regional Resource Centers (Limited Competition U42) Apply for RFA RR 09 003 Funding Number: RFA RR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 09 002 Funding Number: RFA RR 09 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS Apply for PA 04 124 Funding Number: PA 04 124 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) in Nursing Research Apply for PAR 05 091 Funding Number: PAR 05 091 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| IDeA Networks of Biomedical Research Excellence (INBRE) P20 Apply for PAR 08 150 Funding Number: PAR 08 150 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 08 225 Funding Number: PAR 08 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50) Apply for PAR 08 020 Funding Number: PAR 08 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery and Development Groups (NCDDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01/U19) Apply for PAR 08 238 Funding Number: PAR 08 238 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 08 245 Funding Number: PAR 08 245 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomedical Technology Research Resource (P41) Apply for PAR 08 259 Funding Number: PAR 08 259 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diversity promoting Institutions Drug Abuse Research Program (DIDARP) (R24) Apply for PAR 09 011 Funding Number: PAR 09 011 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) U01 Apply for RFA CA 09 503 Funding Number: RFA CA 09 503 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) Apply for RFA DA 09 012 Funding Number: RFA DA 09 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 09 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
